U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C3H5O3.H4N
Molecular Weight 107.1085
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Ammonium lactate

SMILES

[NH4+].CC(O)C([O-])=O

InChI

InChIKey=RZOBLYBZQXQGFY-UHFFFAOYSA-N
InChI=1S/C3H6O3.H3N/c1-2(4)3(5)6;/h2,4H,1H3,(H,5,6);1H3

HIDE SMILES / InChI

Molecular Formula H3N
Molecular Weight 17.0305
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C3H6O3
Molecular Weight 90.0779
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Sodium lactate is primarily indicated as a source of bicarbonate for prevention or control of mild to moderate metabolic acidosis in patients with restricted oral intake whose oxidative processes are not seriously impaired. Sodium Lactate is most commonly associated with an E number of “E325” Sodium Lactate blends are commonly used in meat and poultry products to extend shelf life and increase food safety. They have a broad antimicrobial action and are effective at inhibiting most spoilage and pathogenic bacteria. In addition sodium lactate is used in cosmetics as a humectant, providing moisture.

CNS Activity

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
SODIUM LACTATE IN PLASTIC CONTAINER

Cmax

ValueDoseCo-administeredAnalytePopulation
20.2 μg/mL
39.76 mmol other, intravenous
LACTATE ION, L- plasma
Homo sapiens
2.03 mg/dL
39.76 mmol other, intravenous
LACTIC ACID, D- plasma
Homo sapiens

AUC

ValueDoseCo-administeredAnalytePopulation
53.35 mg × h/dL
39.76 mmol other, intravenous
LACTATE ION, L- plasma
Homo sapiens
4.44 mg × h/dL
39.76 mmol other, intravenous
LACTIC ACID, D- plasma
Homo sapiens

Sourcing

PubMed

Sample Use Guides

In Vivo Use Guide
Sodium Lactate Injection, USP 50 mEq (5 mEq/mL) is administered intravenously only after addition to a larger volume of fluid. The amount of sodium ion and lactate ion to be added to larger volume intravenous fluids should be determined in accordance with the electrolyte requirements of each individual patient. All or part of the content(s) of one (50 mEq in 10 mL) or more vial containers may be added to other intravenous solutions to provide any desired number of milliequivalents of lactate anion (with the same number of milliequivalents of Na+ ). The contents of one container (50 mEq in 10 mL) added to 290 mL of a nonelectrolyte solution or of sterile water for injection will provide 300 mL of an approximately isotonic (1/6 molar) concentration of sodium lactate (1.9%), containing 167 mEq/liter each of Na+ and lactate anion
Route of Administration: Intravenous
In Vitro Use Guide
10 mM sodium lactate inhibits activated T cell motility
Substance Class Chemical
Record UNII
67M901L9NQ
Record Status Validated (UNII)
Record Version